[1] VILACA T, EASTELL R, SCHINI M. Osteoporosis in men. Lancet Diabetes Endocrinol. 2022;10(4): 273-283.
[2] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[3] FUGGLE NR, BEAUDART C, BRUYÈRE O, et al. Evidence-Based Guideline for the management of osteoporosis in men. Nat Rev Rheumatol. 2024;20(4):241-251.
[4] JEON HH, HUANG X, ROJAS CORTEZ L, et al. Inflammation and mechanical force-induced bone remodeling. Periodontol 2000. 2024:10.1111/prd.12619.
[5] KALYANARAMAN H, PAL CHINA S, CASTEEL DE, et al. Crosstalk between androgen receptor and protein kinase G signaling in bone: implications for osteoporosis therapy. Trends Pharmacol Sci. 2025;46(3):279-294.
[6] CHOTIYARNWONG P, MCCLOSKEY EV. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16(8):437-447.
[7] ADAMOPOULOS IE, CHOI Y, TAKAYANAGI H. Novel insights and recent progress in osteoimmunology. Trends Immunol. 2025;46(3):192-194.
[8] FUGGLE N, LASLOP A, RIZZOLI R, et al. Treatment of Osteoporosis and Osteoarthritis in the Oldest Old. Drugs. 2025;85(3):343-360.
[9] DING X, YANG J, WEI Y, et al. The Nexus Between Traditional Chinese Medicine and Immunoporosis: Implications in the Treatment and Management of Osteoporosis. Phytother Res. 2025;39(4):1826-1846.
[10] LI P, LI X, WU Y, et al. A novel AMPK activator hernandezine inhibits LPS-induced TNFα production. Oncotarget. 2017;8(40):67218-67226.
[11] SONG CF, HU YH, MANG ZG, et al. Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway. Acta Pharmacol Sin. 2023;44(4):865-876.
[12] GARCIA D, SHAW RJ. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Mol Cell. 2017;66(6):789-800.
[13] LIU JY, LIU JX, LI R, et al. AMPK, a hub for the microenvironmental regulation of bone homeostasis and diseases. J Cell Physiol. 2024;239(11):31393.
[14] WANG Y, XU Y, ZHANG P, et al.Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARγ pathway. Biochem Pharmacol. 2018;156:385-395.
[15] TANAKA M, INOUE H, TAKAHASHI N, et al. AMPK negatively regulates RANKL-induced osteoclast differentiation by controlling oxidative stress. Free Radic Biol Med. 2023;205:107-115.
[16] LV JL, REN YS, TAN YJ, et al. Hernandezine acts as a CDK4 suppressor inhibiting tumor growth by the CDK4/PKM2/NRF2 axis in colon cancer. Phytomedicine. 2024;131:155775.
[17] BAI J, ZHANG S, CAO J, et al. Hernandezine, a natural herbal alkaloid, ameliorates type 2 diabetes by activating AMPK in two mouse models. Phytomedicine. 2022; 105:154366.
[18] DEMPSTER DW, COMPSTON JE, DREZNER MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013;28(1):2-17.
[19] WANG X, LI X, XIA Y, et al. Hernandezine Regulates Proliferation and Autophagy-Induced Apoptosis in Melanoma Cells. J Nat Prod. 2022;85(5):1351-1362.
[20] LOCATI M, CURTALE G, MANTOVANI A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123-147.
[21] ZHAO X, HE M-J, ZHAO M, et al. Crude Polygalae Radix after boiling with licorice decoction alleviates intestinal mucosal barrier injury of rats by regulating TLR4/NF-κB signaling pathway. J Ethnopharmacol. 2025;346:119661.
[22] YANG R, YU W, LIN L, et al. NAT10 promotes osteoclastogenesis in inflammatory bone loss by catalyzing Fos mRNA ac4C modification and upregulating MAPK signaling pathway. J Adv Res. 2025;72:303-317.
[23] DONG Q, FU H, LI W, et al. Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2. Bone Res. 2025;13(1):20.
[24] BOYLE WJ, SIMONET WS, LACEY DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.
[25] YU B, WANG CY. Osteoporosis and periodontal diseases - An update on their association and mechanistic links. Periodontol 2000. 2022;89(1):99-113.
[26] BILLINGTON E, AGHAJAFARI F, SKULSKY E, et al. Bisphosphonates. BMJ. 2024; 386:e076898.
[27] CHANG JW, TANG CH. The role of macrophage polarization in rheumatoid arthritis and osteoarthritis: Pathogenesis and therapeutic strategies. Int Immunopharmacol. 2024;142(Pt A):113056.
[28] XIANG C, LI H, TANG W. Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases. Pharmacol Res. 2023;187:106566.
[29] BURGAN J, RAHMATI M, LEE M, et al. Innate immune response to bone fracture healing. Bone. 2025;190:117327.
[30] WANG H, LI Y, LI H, et al. T cell related osteoimmunology in fracture healing: Potential targets for augmenting bone regeneration. J Orthop Translat. 2025;51: 82-93.
[31] KODAMA J, KAITO T. Osteoclast Multinucleation: Review of Current Literature. Int J Mol Sci. 2020;21(16):5680.
[32] NAKASHIMA T, HAYASHI M, FUKUNAGA T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17(10):1231-1234.
[33] COMPSTON JE, MCCLUNG MR, LESLIE WD. Osteoporosis. Lancet (London, England). 2019;393(10169):364-376.
[34] AMBROSI TH, MARECIC O, MCARDLE A, et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 2021;597(7875):256-262.
[35] HU K, SHANG Z, YANG X, et al. Macrophage Polarization and the Regulation of Bone Immunity in Bone Homeostasis. J Inflamm Res. 2023;16:3563-3580.
[36] LOI F, CÓRDOVA LA, PAJARINEN J, et al. Inflammation, fracture and bone repair. Bone. 2016;86:119-130.
[37] IBÁÑEZ L, ABOU-EZZI G, CIUCCI T, et al. Inflammatory Osteoclasts Prime TNFα-Producing CD4+ T Cells and Express CX3 CR1. J Bone Miner Res. 2016;31(10): 1899-908.
[38] PANEZ-TORO I, HEYMANN D, GOUIN F, et al. Roles of inflammatory cell infiltrate in periprosthetic osteolysis. Front Immunol. 2023;14:1310262.
[39] TAO H, LI W, ZHANG W, et al. Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways. Pharmacol Res. 2021;174:105967.
[40] WINTER E, DEKKERS O, ANDREASEN C, et al. Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults.Ann Rheum Dis. 2025;84(2):169-187.
[41] GAO Y, XU X, ZHANG X. Targeting different phenotypes of macrophages: A potential strategy for natural products to treat inflammatory bone and joint diseases. Phytomedicine. 2023;118:154952.
[42] BOTT KN, FELDMAN E, DE SOUZA RJ, et al. Lipopolysaccharide-Induced Bone Loss in Rodent Models: A Systematic Review and Meta-Analysis. J Bone Miner Res. 2023;38(1):198-213.
[43] HSIAO SH, LU YJ, YANG CC, et al. Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1. J Nat Prod. 2016;79(8):2135-2142.
[44] LOW A M, BERDIK M, SORMAZ L, et al. Plant alkaloids, tetrandrine and hernandezine, inhibit calcium-depletion stimulated calcium entry in human and bovine endothelial cells. Life Sci. 1996;58(25):2327-2335.
[45] TONG X, GANTA RR, LIU Z. AMP-activated protein kinase (AMPK) regulates autophagy, inflammation and immunity and contributes to osteoclast differentiation and functionabs. Biol Cell. 2020;112(9):251-264.
[46] JIANG L, HE H, TANG Y, et al. Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca2+ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy. Autophagy. 2024;20(11):2388-2404.
[47] AHSAN M, GARNEAU L, AGUER C. The bidirectional relationship between AMPK pathway activation and myokine secretion in skeletal muscle: How it affects energy metabolism]. Front Physiol. 2022;13:1040809.
[48] HSU SH, CHEN LR, CHEN KH. Primary Osteoporosis Induced by Androgen and Estrogen Deficiency: The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments. Int J Mol Sci. 2024;25(22):12139.
[49] MA N, MA D, LIU X, et al. Bisphenol P exposure in C57BL/6 mice caused gut microbiota dysbiosis and induced intestinal barrier disruption via LPS/TLR4/NF-κB signaling pathway. Environ Int. 2023;175:107949.
[50] WU X, QIAO S, WANG W, et al. Melatonin prevents peri‑implantitis via suppression of TLR4/NF-κB. Acta Biomater. 2021;134:325-336.
[51] LI R, FENG J, LI L, et al. Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia/macrophage phenotype. Int Immunopharmacol. 2024;134:112188.
|